CNB
ELV icon

Camden National Bank’s Elevance Health ELV Stock Holding History

Camden National Bank’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,106
Closed -$3.27M – 170
2025
Q3 		$3.27M Sell
10,106
-2,715
-21% -$844K 0.46% 63
2025
Q2 		$4.99M Buy
12,821
+1,994
+18% +$802K 0.72% 55
2025
Q1 		$4.71M Buy
10,827
+399
+4% +$160K 0.7% 58
2024
Q4 		$3.85M Buy
10,428
+4,934
+90% +$2.06M 0.58% 60
2024
Q3 		$2.86M Sell
5,494
-57
-1% -$30.5K 0.41% 66
2024
Q2 		$3.01M Buy
5,551
+674
+14% +$356K 0.46% 61
2024
Q1 		$2.53M Buy
+4,877
New +$2.43M 0.45% 65

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Camden National Bank's ELV Position: Q4 2025 in Review

Camden National Bank sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 10,106 shares — an estimated $3.27M sold.

Camden National Bank first reported a position in ELV in Q1 2024 and held it in 7 quarters. The position peaked at $4.99M in Q2 2025. 1,554 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Camden National Bank reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Camden National Bank sold 10,106 Elevance Health shares in Q4 2025, an estimated $3.27M.
  • Camden National Bank first reported a position in Elevance Health in Q1 2024 and held it in 7 quarters.
  • Camden National Bank's Elevance Health position peaked at $4.99M in Q2 2025.
  • 1,554 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Camden National Bank's 13F filing for Q4 2025, filed 10 Feb 2026.